Quantcast

Synovial Sarcoma - Online Support Group

Nivolumab with or without Votrient (Pazopanib)


#1

The following study had 2 synovial sarcoma patients


#2

The phase 2 trial testing pazopanib/nivolumab combination is not yet recruiting: